Sissetulev kiriAvalik
Euroopa farmakopöa töökava asjus
Ravimiamet · 5. märts 2025
- Viit
- REP-1/1197-1
- Registreeritud
- 5. märts 2025
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2025
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Failid
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: teisipäev, 4. veebruar 2025 13:13
Adressaat: Signe Leito
Teema: Survey: Addition to the WP of Group 17: Sodium Patent Blue and Sodium Patent Blue solution for injection : EDQM-2025-00566-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2025-00566-mail
****************************************************************************
For the attention of NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed addition of the monographs on Sodium Patent Blue and Sodium Patent Blue solution for
injection to the work programme of Group 17.
In order to have access to the survey, please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=554777&lang=en
Deadline for replies: 7 March 2025. Thank you.
With kind regards
On behalf of Amela Saracevic
___
Villy Nikolova
Administrative Support Assistant
European Pharmacopoeia Department
EDQM
Council of Europe
Tel.: +33 (0)3 90 21 64 63 / Fax: +33
(0)3 88 41 27 71
1
https://www.edqm.eu / https://www.edqm.eu/store
Stay connected with the EDQM
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2025-00566-mail
2